{
    "clinical_study": {
        "@rank": "144468", 
        "arm_group": {
            "arm_group_label": "Open myomectomy", 
            "description": "All patients belong to the same group Description includes the surgical technique"
        }, 
        "biospec_descr": {
            "textblock": "Blood samples collected to measure Anti-Mullerian hormone levels"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Anti-Mullerian hormone (AMH) is a marker for ovarian reserve.  It is well known that ovarian\n      surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other\n      surgeries.  We seek to investigate the hormone variations before and after an open\n      myomectomy.\n\n      Hypothesis: Anti-Mullerian hormone levels drop following surgery but return to normal levels\n      in a few months"
        }, 
        "brief_title": "Anti-Mullerian Hormone Levels Before and After an Open Myomectomy", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Anti-Mullerian Hormone", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 to 42 years old\n\n          -  Requiring open myomectomy for any indication\n\n        Exclusion Criteria:\n\n          -  Incapable of informed consent\n\n          -  Use of hormonal contraception or Gonadotropin-releasing hormone agonists in the past\n             3 months\n\n          -  Woman over 42 years old\n\n          -  Post-menopause women\n\n          -  Positive B-human chorionic gonadotropin the day of surgery\n\n          -  Ovarian surgery (at the same time)\n\n          -  Pre-operative AMH below 0.3 ng/mL"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women 18 to 42 tears old Indication for myomectomy by laparotomy"
            }
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01723085", 
            "org_study_id": "AMH"
        }, 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anti-Mullerian hormone", 
            "Myomectomy", 
            "Laparotomy"
        ], 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "contact": {
                "email": "ehimaya@gmail.com", 
                "last_name": "Eric Himaya, MD", 
                "phone": "(514) 890-8000"
            }, 
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H2X 3J4"
                }, 
                "name": "Hopital Saint-Luc"
            }, 
            "investigator": {
                "last_name": "Eric Himaya, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy", 
        "overall_contact": {
            "email": "ehimaya@gmail.com", 
            "last_name": "Eric Himaya, MD", 
            "phone": "(514) 890-8000"
        }, 
        "overall_official": {
            "affiliation": "Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al", 
            "last_name": "Eric Himaya, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Anti-Mullerian Hormone levels before and 6 months after surgery", 
            "measure": "Anti-Mullerian Hormone levels variation", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01723085"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "OVO R & D", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "OVO R & D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}